Table 1 Patient characteristics
Characteristics | Chemotherapy (n = 23) | Chemoradiotherapy (n = 17) | P |
|---|---|---|---|
Age years median (range) | 62 (46–71) | 66 (56–75) | 0.09 |
Male/Female | 19/4 | 15/2 | 1.00 |
BMI median (range) | 23 (18–33) | 26 (21–35) | 0.06 |
Weight change kg median (range) | −10 (−24, +2) | −10 (−21, +6) | 0.62 |
Tumor type | |||
Adenocarcinoma, n (%) | 16 (70) | 13 (76) | 0.73 |
Squamous-cell carcinoma, n (%) | 7 (30) | 4 (24) | 0.73 |
Clinical T stage | |||
T1 | 0 | 0 | _ |
T2 | 9 | 4 | _ |
T3 | 14 | 13 | _ |
Clinical N stage | |||
N0 | 5 | 3 | >0.99 |
N1 | 18 | 14 | >0.99 |
Cardiovascular disease, n (%) | 7 (30) | 10 (59) | 0.11 |
Hypertension, n (%) | 7 (30) | 9 (53) | 0.20 |
Ischemic heart disease, n (%) | 1 (4) | 2 (12) | 0.56 |
Smoking ongoing or previous, n (%) | 10 (43) | 4 (24) | 0.32 |
COPD, n (%) | 5 (22) | 1 (6) | 0.22 |
Anemia, n (%) | 6 (26) | 4 (23) | 1.00 |
Diabetes, n (%) | 3 (13) | 3 (18) | 1.00 |
ASA class, n I/II/III/IV | 0/15/8/0 | 0/10/7/0 | 0.75 |